Symbol
| TGM3
| contributors: mct/npt/shn - updated : 14-05-2015
|
HGNC name
| transglutaminase 3 (E polypeptide, protein-glutamine-gamma-glutamyltransferase)
|
HGNC id
| 11779
|
corresponding disease(s)
|
UHS2
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
tumoral
|  
|  
| --low
|  
|
in esophageal squamous cell carcinoma (significantly inversely correlated with histological grade of esophageal carcinoma) (Liu 2006) | |
Susceptibility
|
to basal cell carcinoma |
Variant & Polymorphism
other
| TGM3 (rs214782) confer risk of basal cell carcinoma |
|
|
Candidate gene
Marker
Therapy target
| | | |
corresponding disease(s)
|
UHS2
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
tumoral
|  
|  
| --low
|  
|
in esophageal squamous cell carcinoma (significantly inversely correlated with histological grade of esophageal carcinoma) (Liu 2006) | |
Susceptibility
|
to basal cell carcinoma |
Variant & Polymorphism
other
| TGM3 (rs214782) confer risk of basal cell carcinoma |
|
|
Candidate gene
Marker
Therapy target
| | | |